Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. [electronic resource]
Producer: 20080923Description: 759-69 p. digitalISSN:- 1527-3350
- Adult
- Alanine Transaminase -- blood
- Antigens, CD -- metabolism
- Antiviral Agents -- therapeutic use
- Apoptosis Regulatory Proteins -- metabolism
- Biopsy
- CD8-Positive T-Lymphocytes -- metabolism
- DNA, Viral -- blood
- Female
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- drug therapy
- Humans
- Interferon-gamma -- metabolism
- Interleukin-10 -- metabolism
- Lamivudine -- therapeutic use
- Liver -- metabolism
- Longitudinal Studies
- Male
- Middle Aged
- Nucleosides -- therapeutic use
- Programmed Cell Death 1 Receptor
- Pyrimidinones -- therapeutic use
- Telbivudine
- Thymidine -- analogs & derivatives
- Treatment Outcome
- Viral Load
- Viremia
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.